Verici Dx Achieves Nationwide Access Following New York State Approval
FRANKLIN, Tenn., June 24, 2026 Verici Dx plc announced that it has received clinical laboratory accreditation from the New...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
FRANKLIN, Tenn., June 24, 2026 Verici Dx plc announced that it has received clinical laboratory accreditation from the New...
SAN ANTONIO, Texas, United States, April 7, 2026 bioAffinity Technologies, Inc. announced that its CyPath® Lung diagnostic test will...
South San Francisco, California, March 16, 2026 Veracyte, Inc. announced the appointment of Kevin Haas, Ph.D., as Chief Development...
